Crossover Versus Stabilometric Platform in Parkinson's Disease

Study Overview
=================
Brief Summary
-----------------
The aims of this study is to assess the efficacy of the crossover on balance in Parkinsonian patients and compare this results with the results of a control group of patients treated with a stabilometric platform.

Detailed Description
-----------------
Parkinson's disease (PD) is a neurodegenerative disorder characterized by different motor symptoms (rigidity, akinesia, tremor and impairment of balance and gait). Even though pharmacological treatment has changed the natural course of the disease, balance worsens over time and leads to falls. The aims of this study is to assess the efficacy of the crossover (group 1) on balance in Parkinsonian patients and compare this results with the results of a control group of patients treated with a stabilometric platform (group 2). The group 1 executed 6 days/week for a 4-weeks cycle a crossover protocol based on the first 4 level of resistance and a training which lasts at most 5 minutes. The group 2 executed 6 days/week for a 4-weeks cycle different exercises with the stabilometric platform in monopodalic and in bipodalic standing.

Official Title
-----------------
Effect of Two Different Rehabilitation Programs on Balance in Parkinsonian Patients: Crossover Versus Stabilometric Platform

Conditions
-----------------
Parkinson's Disease

Intervention / Treatment
-----------------
* Other: Crossover
* Other: Stabilometric Platform


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: PD in stage III Hoen&Yahr according to Gelb et la. with the ability to walk without any assistance and with Mini Mental State Examination (MMSE) score > 26 Exclusion Criteria: MMSE < 26 Coexistence of other neurological diseases PD patients with relevant orthopedic, rheumatic and muscular conditions

Ages Eligible for Study
-----------------
Minimum Age: 50 Years
Maximum Age: 75 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| PD patients cross-over treatment<br>30 PD patients (according to Gelb et al) in Hoen&Yahr stage 3, underwent cross-over treatment with the ability to walk without any assistance with mini-mental state examination score >26. | Other: Crossover<br>* Crossover cycle<br>|
| PD patients stabilometric platform<br>30 PD patients (according to Gelb et al) in Hoen&Yahr stage 3, underwent stabilometric platform treatment, with the ability to walk without any assistance with mini-mental state examination score >26. | Other: Stabilometric Platform<br>* This Stabilometric plate allows to assess the balance with an objective and reliable measurement, in both standard static or dynamic unstable condition<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| BBS | Berg Balance Scale | One month | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| 6MWT | Six minutes walking test | One month | 
| TUG | Time up and Go test | One month | 
| UPDRS II | Unified Parkinson's disease Rating Scale II | One month | 
| UPDRS III | Unified Parkinson's disease Rating Scale III | One month | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Balance